Trust Company’s Edwards Lifesciences EW Stock Holding History

Trust Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$452	Sell	5 -720	-99%	-$60.3K	﹤0.01%	783
2026 Q1	$58.1K	Hold	725	–	–	0.01%	280
2025 Q4	$61.8K	Sell	725 -205	-22%	-$16.8K	0.01%	266
2025 Q3	$72.3K	Buy	930 +720	+343%	+$56.3K	0.01%	196
2025 Q2	$16.4K	Hold	210	–	–	﹤0.01%	289
2025 Q1	$15.2K	Buy	+210	New	+$15K	﹤0.01%	308
2018 Q4	–	Sell	-720	Closed	-$42K	–	332
2018 Q3	$42K	Hold	720	–	–	0.02%	164
2018 Q2	$35K	Hold	720	–	–	0.02%	190
2018 Q1	$33K	Hold	720	–	–	0.01%	188
2017 Q4	$27K	Hold	720	–	–	0.01%	201
2017 Q3	$26K	Hold	720	–	–	0.01%	181
2017 Q2	$28K	Hold	720	–	–	0.01%	192
2017 Q1	$23K	Hold	720	–	–	0.01%	226
2016 Q4	$22K	Hold	720	–	–	0.01%	229
2016 Q3	$29K	Sell	720 -720	-50%	-$27.1K	0.01%	215
2016 Q2	$48K	Hold	1,440	–	–	0.02%	177
2016 Q1	$42K	Hold	1,440	–	–	0.02%	180
2015 Q4	$37.9K	Hold	1,440	–	–	0.02%	184
2015 Q3	$34K	Hold	1,440	–	–	0.02%	203
2015 Q2	$34K	Buy	+1,440	New	+$32.5K	0.02%	211

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Trust Company's EW Position: Q2 2026 in Review

Trust Company reduced its Edwards Lifesciences (EW) stake by 99% in Q2 2026, selling an estimated $60.3K and leaving 5 shares worth $452. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Trust Company first reported a position in EW in Q2 2015 and has held it in 20 quarters since. The position peaked at $72.3K in Q3 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Trust Company held 5 shares of Edwards Lifesciences worth $452 as of Q2 2026.
Trust Company sold 720 Edwards Lifesciences shares in Q2 2026, an estimated $60.3K.
Edwards Lifesciences made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #783 holding.
Trust Company first reported a position in Edwards Lifesciences in Q2 2015 and has held it in 20 quarters since.
Trust Company's Edwards Lifesciences position peaked at $72.3K in Q3 2025.
1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.